Zhenguo Cheng

1.3k total citations
40 papers, 929 citations indexed

About

Zhenguo Cheng is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Zhenguo Cheng has authored 40 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Genetics and 16 papers in Oncology. Recurrent topics in Zhenguo Cheng's work include Virus-based gene therapy research (15 papers), CAR-T cell therapy research (10 papers) and Cancer Research and Treatments (8 papers). Zhenguo Cheng is often cited by papers focused on Virus-based gene therapy research (15 papers), CAR-T cell therapy research (10 papers) and Cancer Research and Treatments (8 papers). Zhenguo Cheng collaborates with scholars based in China, United Kingdom and Australia. Zhenguo Cheng's co-authors include Yaohe Wang, Funan Liu, Louisa S. Chard, Hanwei Huang, Feng Li, Lihong Wang, Siwei Pan, Mengchi Sun, Yanshu Li and Hongyan Zhang and has published in prestigious journals such as Nature Communications, Nano Letters and ACS Nano.

In The Last Decade

Zhenguo Cheng

38 papers receiving 922 citations

Peers

Countries citing papers authored by Zhenguo Cheng

Since Specialization

Citations

This map shows the geographic impact of Zhenguo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenguo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenguo Cheng more than expected).

Fields of papers citing papers by Zhenguo Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenguo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenguo Cheng. The network helps show where Zhenguo Cheng may publish in the future.

Co-authorship network of co-authors of Zhenguo Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenguo Cheng. A scholar is included among the top collaborators of Zhenguo Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenguo Cheng. Zhenguo Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bispecific Nanosystems Enable Multieffector Immune Cell Retargeting for Hematologic Malignancy Therapy 2025 ·Advanced Science ·(unknown), Xin Li, (unknown), (unknown), Sven Borchmann, Zhenguo Cheng, Yaohe Wang, (unknown), Jian Song, (unknown), Xiuyun Liu, Yue Teng, Zhiyuan Shi	0
2	The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors 2024 ·Cancer Letters ·Lihong Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Zhenguo Cheng, Yaohe Wang	29
3	Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects 2023 ·Advanced Science ·Mingyang Liu, Ruizhe Zhang, Hanwei Huang, Pengfei Liu, (unknown), Hu Wu, (unknown), (unknown), (unknown), Zhenguo Cheng, Hongyu Liu, Önder Ergönül, Füsun Can, Defang Ouyang, Zhenning Wang, Zhiqing Pang, Funan Liu	13
4	Virus-Protein Corona Replacement Strategy to Improve the Antitumor Efficacy of Intravenously Injected Oncolytic Adenovirus 2023 ·ACS Nano ·Hanwei Huang, Mingyang Liu, Mengchi Sun, (unknown), Siwei Pan, Pengfei Liu, Zhenguo Cheng, Önder Ergönül, Füsun Can, Zhenning Wang, Zhiqing Pang, Funan Liu	15
5	A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma 2023 ·Cancer Letters ·Lihong Wang, (unknown), Yangyang Wu, Jingjing Wang, (unknown), Jianyao Wang, Haoran Guo, Na Zhang, (unknown), (unknown), Yuanyuan Zhao, Jinxin Miao, (unknown), Louisa S. Chard, Danhua Zhang, Nicholas R. Lemoine, Zhenguo Cheng, Yaohe Wang	7
6	FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis 2023 ·Theranostics ·Siwei Pan, Jiaming Zhu, Pengfei Liu, (unknown), Siyu Zhang, Wen An, Yuxin Tong, Zhenguo Cheng, Funan Liu	17
7	Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy 2023 ·Nature Communications ·(unknown), Mengchi Sun, Hanwei Huang, Wanxu Huang, Siwei Pan, Pengfei Liu, B. Li, Zhenguo Cheng, Zhonggui He, Funan Liu, Jin Sun	67
8	Antigen-capturing oncolytic adenoviruses along with IDO blockade for improved tumor immunotherapy 2023 ·Nano Today ·Xu Chen, Keman Cheng, Xinwei Wang, Jingjing Liu, Jie Liang, Guangna Liu, (unknown), Ming Tang, Dingfei Qian, Liting Chen, Zhenguo Cheng, Zhenning Wang, Xiao Zhao, Funan Liu	11
9	Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene 2022 ·Molecular Therapy — Oncolytics ·(unknown), Qianqian Song, Junqi Li, Louisa S. Chard, Yuanyuan Jiang, Bin Qin, Jianyao Wang, (unknown), Zhenguo Cheng, Zhimin Wang, Nicholas R. Lemoine, Shuangshuang Lu, Yaohe Wang	8
10	Natural products targeting glycolysis in cancer 2022 ·Frontiers in Pharmacology ·Yuanyuan Zhao, Louisa S. Chard, Zhenguo Cheng, Yaohe Wang, Lingling Si	20
11	Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma 2022 ·Frontiers in Immunology ·Zhizhong Wang, Zhenguo Cheng, Shuangshuang Lu, Louisa S. Chard, Jun Wang, Yongjun Guo, Yaohe Wang	7
12	Full encapsulation of oncolytic virus using hybrid erythroctye-liposome membranes for augmented anti-refractory tumor effectiveness 2022 ·Nano Today ·Hanwei Huang, Mengchi Sun, Mingyang Liu, Siwei Pan, Pengfei Liu, Zhenguo Cheng, Jia Li, Huimian Xu, Funan Liu, Zhiqing Pang	23
13	A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Giulia Marelli, Louisa S. Chard, Ming Yuan, (unknown), Jinxin Miao, Zhenguo Cheng, Zhongxian Zhang, Peng Liu, Jahangir Ahmed, Rathi Gangeswaran, Nicholas R. Lemoine, Yaohe Wang	30
14	Promising xenograft animal model recapitulating the features of human pancreatic cancer 2020 ·World Journal of Gastroenterology ·Jinxin Miao, Jianyao Wang, Haoze Li, Haoran Guo, Louisa S. Chard, Zhongxian Zhang, Zhenguo Cheng, Dongling Gao, Jianzeng Dong, (unknown), Yaohe Wang	19
15	A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells 2018 ·Oncogene ·Yanshu Li, Hongyan Zhang, Yue Zhao, Chunyu Wang, Zhenguo Cheng, (unknown), (unknown), Furong Liu, Jiabin Li, Yan Li, Yang Li, (unknown), Rui Xue, Yuee Teng, Yunpeng Liu, Liu Cao, Rakesh Kumar, Feng Jin, Feng Li	34
16	Disintegration, functionalization and drug-delivery application of nanodiamond 2018 ·Acta Physica Sinica ·(unknown), Qi Zhao, Zhenguo Cheng, Lixia Su, (unknown)	4
17	GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC 2017 ·Tumor Biology ·Baocheng Gong, Yuan Li, Zhenguo Cheng, Pengliang Wang, Lei Luo, Hanwei Huang, (unknown), Funan Liu	16
18	A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells 2017 ·Molecular Therapy — Nucleic Acids ·Funan Liu, Zhenguo Cheng, Xiaodong Li, Yanshu Li, Hongyan Zhang, Jiabin Li, Furong Liu, Huimian Xu, Feng Li	28
19	CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer 2015 ·Cellular Signalling ·(unknown), Zhenguo Cheng, Funan Liu, Hongyan Zhang, Jiabin Li, Feng Li	14
20	miR-133 is a key negative regulator of CDC42–PAK pathway in gastric cancer 2014 ·Cellular Signalling ·Zhenguo Cheng, Funan Liu, (unknown), Yanshu Li, Hongyan Zhang, Feng Li	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact